U.S. Markets closed
  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     
  • Dow 30

    30,932.37
    -469.64 (-1.50%)
     
  • Nasdaq

    13,192.35
    +72.92 (+0.56%)
     
  • Russell 2000

    2,201.05
    +0.88 (+0.04%)
     
  • Crude Oil

    61.66
    -1.87 (-2.94%)
     
  • Gold

    1,733.00
    -42.40 (-2.39%)
     
  • Silver

    26.70
    -0.98 (-3.56%)
     
  • EUR/USD

    1.2088
    -0.0099 (-0.8099%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • Vix

    27.95
    -0.94 (-3.25%)
     
  • GBP/USD

    1.3922
    -0.0091 (-0.6460%)
     
  • USD/JPY

    106.5500
    +0.3200 (+0.3012%)
     
  • BTC-USD

    44,159.30
    -3,401.29 (-7.15%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

New Strong Sell Stocks for December 9th

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

GreenTree Hospitality Group Ltd. GHG develops leased-and-operated and franchised-and-managed hotels. The Zacks Consensus Estimate for its current year earnings has been revised 6.5% downward over the last 30 days.

Neurocrine Biosciences, Inc. NBIX is a commercial-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of neurological, endocrine, and psychiatric disorders. The Zacks Consensus Estimate for its current year earnings has been revised 40.5% downward over the last 30 days.

Solid Biosciences Inc. SLDB is a life science company, engages in developing therapies for duchenne muscular dystrophy. The Zacks Consensus Estimate for its current year earnings has been revised 3.9% downward over the last 30 days.

Fennec Pharmaceuticals Inc. FENC is a biopharmaceutical company that develops product candidates for use in the treatment of cancer. The Zacks Consensus Estimate for its current year earnings has been revised 5% downward over the last 30 days.

NewAge, Inc. NBEV develops, markets, sells, and distributes healthy liquid dietary supplements and ready-to-drink beverages. The Zacks Consensus Estimate for its current year earnings has been revised 31.3% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Neurocrine Biosciences, Inc. (NBIX) : Free Stock Analysis Report
 
New Age Beverage Corporation (NBEV) : Free Stock Analysis Report
 
Adherex Technologies Inc. (FENC) : Free Stock Analysis Report
 
Solid Biosciences Inc. (SLDB) : Free Stock Analysis Report
 
GreenTree Hospitality Group Ltd. Sponsored ADR (GHG) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research